updated consensus approach from the Transatlantic Australasian RPS Working Group . Ann Surg Oncol 2021 ; 28 : 7873 – 7888 . 10.1245/s10434-021-09654-z 6. Salerno KE , Alektiar KM , Baldini EH , Radiation therapy for treatment of
Search Results
Role of Radiation Therapy in Retroperitoneal Sarcoma
Kilian E. Salerno and Elizabeth H. Baldini
Combined Chemotherapy and Radiation Therapy for Cervical Cancer
David H. Moore
. CA Cancer J Clin 2003 ; 53 : 5 – 26 . 2 Fu KK . Biological basis for the interaction of chemotherapeutic agents and radiation therapy . Cancer 1985 ; 55 : 2123 – 2130 . 3 Sinclair WK . Hydroxyurea: Effects on Chinese
Contemporary Radiation Therapy in Combined Modality Therapy for Hodgkin Lymphoma
Amol K. Narang and Stephanie A. Terezakis
, radiation therapy (RT) alone was the backbone of management for Hodgkin lymphoma (HL). Despite high tumor control rates with RT alone, large treatment fields were required that included uninvolved lymph nodes at risk. As a result, patients incurred late
Radiation Therapy Advances for Treatment of Anal Cancer
Joseph M. Pepek, Christopher G. Willett, and Brian G. Czito
Techniques for the treatment of anal cancer have developed in parallel with technologic advances in radiation therapy (RT). Combined chemotherapy and RT has replaced radical surgical resection as the cornerstone of treatment for anal malignancies
Radiation Therapy in Operable and Locally Advanced Pancreatic Cancer
Andrew H. Ko and Christopher H. Crane
W hen considering the role of radiation therapy in operable and locally advanced pancreatic cancer, it becomes necessary to examine the patterns of locoregional versus systemic failure in these disease settings. For example, data from single
Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy
Lucas K. Vitzthum, Chris Straka, Reith R. Sarkar, Rana McKay, J. Michael Randall, Ajay Sandhu, James D. Murphy, and Brent S. Rose
Background Multiple randomized controlled trials have shown that androgen deprivation therapy (ADT) improves outcomes for men with intermediate- or high-risk prostate cancer (PCa) treated with radiation therapy (RT). 1 – 4 These trials used
Evolution of Radiation Therapy Within the German Hodgkin Study Group Trials
Hans Theodor Eich, Jan Kriz, and Rolf-Peter Müller
analyses, never as prospective randomized trials, and mostly for radiation therapy only. No substantial data exist for the combined modality treatment of radiotherapy and chemotherapy. Therefore, the HD10 trial was initiated to answer 2 questions for early
Salvage or Adjuvant Radiation Therapy: Counseling Patients on the Benefits
Matthew E. Nielsen, Bruce J. Trock, and Patrick C. Walsh
. 17. Stephenson AJ Scardino PT Kattan MW . Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy . J Clin Oncol 2007 ; 25 : 2035 – 2041 . Erratum in: J Clin Oncol 2007;25:4153 . 18
NCCN Guidelines Update: Evolving Radiation Therapy Recommendations for Breast Cancer
Kilian E. Salerno
commercial interests with the manufacturers of any products discussed in this article or their competitors. References 1. Whelan TJ Pignol JP Levine MN . Long-term results of hypofractionated radiation therapy for breast cancer . N Engl J
Impact of Immunotherapy on the Survival of Patients With Cancer and Brain Metastases
Saber Amin, Michael Baine, Jane Meza, and Chi Lin
, with a median survival time of 4 to 16 months, depending on the primary site. 4 – 6 Current treatment modalities available for the treatment of BMs are surgery, whole-brain radiation therapy (RT), and stereotactic radiosurgery (SRS). 7 , 8 The most
